StonvexLoading…
StonvexStonvexStonvexCore line items from PH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $15.74B | $10.26B | $5.08B | $19.85B |
Operating Income | $3.59B | $2.37B | $1.18B | $4.35B |
Net Income | $2.56B | $1.65B | $808.00M | $3.53B |
EPS (Diluted) | $19.95 | $12.89 | $6.29 | $27.12 |
Total Assets | $30.68B | $30.51B | $30.68B | $29.49B |
Total Liabilities | $16.06B | $16.19B | $16.89B | $15.80B |
Cash & Equivalents | $476.00M | $427.00M | $473.00M | $467.00M |
Free Cash Flow OCF − CapEx | $2.34B | $1.46B | $693.00M | $3.34B |
Shares Outstanding | 128.20M | 128.20M | 128.40M | 130.20M |